US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,619.43

+39.032.47%

Number of Gainers:5

Number of Losers:2

Number of Flat:- -

PE:- -

High:1,638.02

Open:1,595.38

Low:1,588.79

Close:1,580.40

Volume:59.57M

Turnover:5.29B

Market Cap:1.68T

Float Cap:1.62T

Loading ...

Pfizer (PFE) Quietly Builds New Cancer And RSV Powerhouse

Viking Therapeutics Slides As Cash Raise Spooks Wall Street

Weight Loss Maintenance Data Could Be A Big Test For Viking Therapeutics Stock (VKTX)

Simply Wall St.

Pfizer (PFE) Receives a Hold from Leerink Partners

Eli Lilly & Co (LLY) Gets a Buy from RBC Capital

Novo Nordisk Says FDA Review of Hemophilia Drug is Hitting Delays

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Altimmune Files Form 3 for Principal Accounting Officer Richard Thomas Menziuso

Former Eli Lilly Exec Sells Wyoming Estate for Close to $39.5 Million

Eli Lilly announces FDA approves additional indication for Jaypirca

Lilly Says FDA Approves Expanded First-Line Cll/sll Use for Jaypirca

Lilly's Jaypirca (Pirtobrutinib), the First-and-Only Approved Non-Covalent Btk Inhibitor, Receives Expanded Indication from U.S. FDA for Certain Patients with Previously Untreated Cll/Sll

THOMSON REUTERS

Pfizer Says Litfulo Safety Profile in NSV Consistent with Alopecia Areata

Pfizer Tilrekimig Data Support TSLP Role in Atopic Dermatitis, UBS Says

MT Newswires Live

Novo Nordisk Tests Zenagamtide Dosing to Sharpen Its Obesity Drug Pipeline

Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise

Pfizer’s TACTIVE-U Breast Cancer Combo Trial Reaches Key Milestone

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Pfizer Says Phase 3 Trials Show Litfulo Improves Repigmentation in Nonsegmental Vitiligo Patients at Week 52

Pfizer - to Submit Litfulo Phase 3 Data to FDA and Ema

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK4599/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1619.4291,"timestamp":1791403199999,"preClose":1580.3972,"halted":0,"volume":59571221,"delay":0,"changeRate":0.024697,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":39.03186,"latestTime":"10-07 16:00:00 EDT","open":1595.3789,"high":1638.022,"low":1588.7897,"amount":5293316498.34071,"amplitude":0.031152,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791466200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.511599,"peRate":28.026625,"turnoverRate":0.005593,"increases":5,"decrements":2,"flats":0,"marketCap":1682277428576,"floatMarketCap":1623466483200},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1638.022,"amplitude":0.031152,"preClose":1580.3972,"low":1588.7897,"pbRate":"9.511599","latestPrice":1619.4291,"volume":59571221,"delay":0,"open":1595.3789,"prevYearClose":1494.5856,"prevWeekClose":1567.9943,"prevMonthClose":1599.3274,"prevQuarterClose":1599.3274,"fiveDayClose":1599.3274,"twentyDayClose":1569.7671,"sixtyDayClose":1575.6797,"secType":"PLATE","market":"US","turnoverRate":0.005593,"peRate":28.026625,"marketCap":1682277428576,"floatMarketCap":1623466483200,"timestamp":1791403199999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672726308","title":"Pfizer (PFE) Quietly Builds New Cancer And RSV Powerhouse","url":"https://stock-news.laohu8.com/highlight/detail?id=2672726308","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672726308?lang=en_us&edition=fundamental","pubTime":"2026-10-03 23:02","pubTimestamp":1791039728,"startTime":"0","endTime":"0","summary":"Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer Inc. is pushing deeper into onc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/pfizer-pfe-quietly-builds-new-cancer-and-rsv-powerhouse?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/pfizer-pfe-quietly-builds-new-cancer-and-rsv-powerhouse?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999002232.USD","BK4585","IE0002270589.USD","LU0122379950.USD","LU1883839398.USD","SG9999013999.USD","LU1894683264.USD","LU0306806265.USD","IE00B19Z3581.USD","BK4533","LU0225284248.USD","LU0321505439.SGD","SG9999003800.SGD","LU0170899867.USD","LU0321505868.SGD","BK4581","SG9999002224.SGD","SG9999001176.SGD","IE00BBT3K403.USD","LU1066053197.SGD","LU0289739699.SGD","BK4568","IE000M9KFDE8.USD","IE00BLSP4239.USD","BK4007","LU0306807586.USD","LU2596442595.SGD","IE00B3T34201.USD","LU0225771236.USD","IE00B19Z3B42.SGD","PFE","BK4592","LU0456855351.SGD","IE00BLSP4452.SGD","BK4534","LU0234572021.USD","LU0868494617.USD","SG9999001176.USD","SG9999011175.SGD","LU1066051498.USD","BK4599","OZEM","LU1057294990.SGD","BK4550","BK4588","LU1894683348.USD","SGXZ57979304.SGD","LU0058720904.USD","LU1023059063.AUD","LU0985481810.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672224725","title":"Viking Therapeutics Slides As Cash Raise Spooks Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2672224725","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672224725?lang=en_us&edition=fundamental","pubTime":"2026-10-03 22:02","pubTimestamp":1791036129,"startTime":"0","endTime":"0","summary":"Viking Therapeutics ( ($VKTX) ) has fallen by -9.36%. Read on to learn why. Viking Therapeutics shares fell 9.36% over the past week as investors r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/viking-therapeutics-slides-as-cash-raise-spooks-wall-street?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/viking-therapeutics-slides-as-cash-raise-spooks-wall-street?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["THNR","OZEM","BK4599","BK4585","BK4588","BK4139","VKTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672740793","title":"Weight Loss Maintenance Data Could Be A Big Test For Viking Therapeutics Stock (VKTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672740793","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672740793?lang=en_us&edition=fundamental","pubTime":"2026-10-03 14:21","pubTimestamp":1791008482,"startTime":"0","endTime":"0","summary":"Viking Therapeutics completed a US$225 million convertible note offering and a US$275.0 million follow-on equity sale shortly after reporting past positive top line VK2735 maintenance data in obesity.\nThe pairing of strong VK2735 weight maintenance results with fresh debt and equity raises gives Viking Therapeutics more funding flexibility to run longer, larger trials and expand its obesity pipeline without relying only on existing cash.\nThis article examines how Viking Therapeutics'...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vktx/viking-therapeutics/news/weight-loss-maintenance-data-could-be-a-big-test-for-viking","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vktx/viking-therapeutics/news/weight-loss-maintenance-data-could-be-a-big-test-for-viking","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","VKTX","BK4585","BK4588","BK4599","OZEM","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672747749","title":"Pfizer (PFE) Receives a Hold from Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2672747749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672747749?lang=en_us&edition=fundamental","pubTime":"2026-10-03 12:25","pubTimestamp":1791001557,"startTime":"0","endTime":"0","summary":"In a report released yesterday, from Leerink Partners maintained a Hold rating on Pfizer. The company’s shares closed yesterday at $27.80. Currentl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pfizer-pfe-receives-a-hold-from-leerink-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pfizer-pfe-receives-a-hold-from-leerink-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0225771236.USD","LU0985481810.HKD","BK4581","BK4534","LU0225284248.USD","SG9999003800.SGD","IE00B3T34201.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0306807586.USD","IE00BBT3K403.USD","BK4592","SG9999011175.SGD","BK4550","PFE","IE0002270589.USD","LU0456855351.SGD","LU0321505868.SGD","BK4588","IE00B19Z3B42.SGD","SG9999002224.SGD","LU1883839398.USD","LU2596442595.SGD","BK4599","OZEM","LU0170899867.USD","LU0122379950.USD","LU0868494617.USD","LU1066053197.SGD","BK4007","LU0289739699.SGD","LU0306806265.USD","LU1057294990.SGD","LU1066051498.USD","BK4568","IE00BLSP4452.SGD","LU1894683348.USD","BK4533","BK4585","LU0234572021.USD","SG9999001176.SGD","SG9999001176.USD","SG9999002232.USD","SGXZ57979304.SGD","LU1023059063.AUD","LU0321505439.SGD","LU1894683264.USD","SG9999013999.USD","IE00BLSP4239.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672742287","title":"Eli Lilly & Co (LLY) Gets a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2672742287","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672742287?lang=en_us&edition=fundamental","pubTime":"2026-10-03 09:46","pubTimestamp":1790992004,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Trung Huynh maintained a Buy rating on Eli Lilly & Co on October 1 and set a price target of $1,500.00. The company’s shares cl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/eli-lilly-co-lly-gets-a-buy-from-rbc-capital-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/eli-lilly-co-lly-gets-a-buy-from-rbc-capital-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IE00BJJMRX11.SGD","FTXH","LU0289739699.SGD","LU0316494557.USD","IE0005OL40V9.USD","LU1232071149.USD","LU1323610961.USD","BK4599","IE0002141913.USD","LU1145028129.USD","LU1035775433.USD","SG9999014898.SGD","LU2471134523.USD","LU2552382058.USD","LU0820562030.AUD","MHIP","LU0198837287.USD","IE00B2B36J28.USD","LU0889565916.HKD","LU0106261372.USD","LLYX","LU2491050154.USD","BK4588","CANC","LU1989771016.USD","LU2112291526.USD","AGNG","LU2271345857.HKD","LU2023250504.SGD","LU0323591593.USD","LU0353189763.USD","LU1917777945.USD","LU2237443465.HKD","LU2357305700.SGD","LU0345770308.USD","LU0823434740.USD","LU1057294990.SGD","LU1623119135.USD","LU0158827781.USD","IE00B1BXHZ80.USD","LU2168564065.EUR","LU2213496289.HKD","SG9999015952.SGD","LU1551013342.USD","LU0061475181.USD","LU0058720904.USD","SGXZ81514606.USD","IYH","LU0234572021.USD","ELIS","LU0006306889.USD","LU0882574055.USD","LU0109391861.USD","LU2089283258.USD","LU0097036916.USD","LU2756315318.SGD","LU0708995401.HKD","LU2089984988.USD","SG9999015978.USD","LU2111349929.HKD","LU1548497426.USD","LU2746668461.USD","LU0466842654.USD","LU2750360997.AUD","LU0210536198.USD","MEDX","LU2063271972.USD","SG9999013999.USD","LU0943347566.SGD","IHE","IE00BJLML261.HKD","IE00BFSS8Q28.SGD","LU0882574139.USD","LU2471134796.USD","LU0640476718.USD","LU0122379950.USD","LU0432979614.USD","LU0823416689.USD","LU1814569148.SGD","LU0225283273.USD","LU1868836914.USD","LU2023250330.USD","LU1629891620.HKD","LU2265009873.SGD","LU0079474960.USD","LU1280957306.USD","GB00BDT5M118.USD","LU2168564222.USD","IE00BFSS7M15.SGD","LU2211815571.USD","SG9999014906.USD","LU2237443978.SGD","JDOC","LU2462591350.SGD","LU0964807845.USD","LU2461242641.AUD","LU2471134879.HKD","LU2552382215.SGD","LU2552382132.HKD","LU0203202063.USD","LU0345770993.USD","LU1291159041.SGD","LU2491050071.SGD","LLY","LU1267930730.SGD","LLII","SG9999014914.USD","TRUH","LU1127390331.HKD","VHT","LU1868837136.USD","LU2023251221.USD","SG9999015986.USD","LU0256863902.USD","SGXZ51526630.SGD","IE00B1XK9C88.USD","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU2236285917.USD","LU2237443895.HKD","LU2361044949.HKD","LU0672654240.SGD","LU1366192091.USD","IE00BJJMRY28.SGD","LU0158827948.USD","SG9999014880.SGD","LU2089284900.SGD","LU1023059063.AUD","ELIL","LU2324357040.USD","LU0266013472.USD","SGXZ31699556.SGD","LU2237443382.USD","PJP","LU0238689110.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0354030438.USD","IE00BKPKM429.USD","LU0094547139.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","SG9999001176.SGD","LU2468319806.SGD","LU1988902786.USD","LU2360106947.USD","TMED","LU2361045086.USD","HRTS","LU1712237335.SGD","SG9999018857.SGD","LU2168563687.JPY","SGXZ57979304.SGD","LU1868836591.USD","LU2896262040.SGD","LU1868836757.USD","LU0417517546.SGD","LU0823434583.USD","LU2168564149.EUR","LU2264538146.SGD","IE0009355771.USD","LU0385154629.USD","LU2417539215.USD","LU2237443549.SGD","LU2756315664.SGD","IE00BKDWB100.SGD","RXL","IE0004445015.USD","LU0133085943.USD","LU1979441026.SGD","LU2106854487.HKD","IE00BK4W5L77.USD","LU0471298777.SGD","IE00B7KXQ091.USD","CURE","ILDR","LU0689472784.USD","LU0096364046.USD","LU0256863811.USD","BK4516","LU1551013425.SGD","IE0001KFT4U8.USD","WDNA","LU0203201768.USD","LU2602419157.SGD","LU0683600562.USD","LU2168564495.EUR","IE00BN29S564.USD","LU0114720955.EUR","LU0320765992.SGD","SG9999018865.SGD","LU1064131342.USD","LU1691799644.USD","LU0109394709.USD","FHLC","SG9999017495.SGD","THNR","MEDI","IE00B4JS1V06.HKD","LU0320765059.SGD","BK4534","IE00BWXC8680.SGD","LU1983299246.USD","LU2237438978.USD","LU2746668974.SGD","LU1720051108.HKD","LU0787776722.HKD","OZEM","LLYZ","LU1061106388.HKD","LU0353189680.USD","LU0820561909.HKD","GDOC","BK4581","LU0456855351.SGD","LU1974910355.USD","LU1804176565.USD","LU2491049909.HKD","IXJ","LU0174119429.USD","IE00BK4W5M84.HKD","SG9999001176.USD","LU2456880835.USD","IE00B775H168.HKD","LU1868837300.USD","LU2750360641.GBP","LU2462157665.USD","LU0820561818.USD","LU2237443622.USD","LU2471134952.CNY","SG9999015945.SGD","LU1093756168.USD","LU0786609619.USD","LU2361044865.SGD","PPH","BK4533","LU1069344957.HKD","LU2087625088.SGD","SGXZ99366536.SGD","XLV","LU2028103732.USD","LU0354030511.USD","LU2108987350.USD","IE0004445239.USD","LU0471298694.HKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672741768","title":"Novo Nordisk Says FDA Review of Hemophilia Drug is Hitting Delays","url":"https://stock-news.laohu8.com/highlight/detail?id=2672741768","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672741768?lang=en_us&edition=fundamental","pubTime":"2026-10-03 06:13","pubTimestamp":1790979180,"startTime":"0","endTime":"0","summary":"Novo Nordisk received notice from the Food and Drug Administration that its review of denecimig for the treatment of hemophilia A is still ongoing.The FDA hasn't communicated a new timeline for expected regulatory action on the biologics license application, the drug company said Friday.The cause for the extension of the agency's review is ongoing remediation activities at Novo's manufacturing facility. The FDA performed a pre-license inspection of the site and provided feedback after the company first submitted its license application.Novo submitted the application to the FDA in September 2025 for denecimig as a treatment of hemophilia A in adult and pediatric patients. At that time, it was anticipating a regulatory decision in the third quarter of 2026.The FDA hasn't identified deficiencies related to the clinical efficacy or safety data of the drug, Novo said. The company is continuing implementation of the facility remediation activities in response to the FDA's feedback.The prolon","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPH","BK4532","NVO","BK4588","NVOX","IE00BZ1G4Q59.USD","LU1093756168.USD","OZEM","BK4599","BK4007","LU0154236417.USD","BK4585","THNR","NVOC","LU1093756325.SGD","IE00BKVL7J92.USD","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749900","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749900","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749900?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:34","pubTimestamp":1790973240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.04% to $403.04 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.73% to 7,722.72 and the Dow Jones Industrial Average  rising 0.49% to 51,176.96.This was the stock's third consecutive day of losses.Amgen Inc. closed 9.84% short of its 52-week high of $447.03, which the company achieved on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.02% to $256.03, Pfizer Inc.  fell 1.14% to $27.80, and AbbVie Inc.  rose 1.11% to $262.82.Trading volume  eclipsed its 50-day average volume of 2.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0058720904.USD","BK4566","LU2242646821.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0109394709.USD","IBB","SG9999001440.SGD","BK4139","AMGN","BK4581","LU1023059063.AUD","IE0002141913.USD","04332","IE00BJT1NW94.SGD","LU2468319806.SGD","LU2112291526.USD","TBXU","BK4533","LU0868494617.USD","LU2089984988.USD","LU1571399168.USD","IBBQ","LU0122379950.USD","BIB","IE00BFTCPJ56.SGD","BK4534","BK4599","LU0289739699.SGD","IE0009355771.USD","PJP","BK4588","IE00B2B36J28.USD","LU1061106388.HKD","PBE","BBH","BK4585","LU1057294990.SGD","LU2242652126.USD","LU1983299246.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672174980","title":"Altimmune Files Form 3 for Principal Accounting Officer Richard Thomas Menziuso","url":"https://stock-news.laohu8.com/highlight/detail?id=2672174980","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672174980?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:16","pubTimestamp":1790972219,"startTime":"0","endTime":"0","summary":"Altimmune files Form 3 for Principal Accounting Officer Richard Thomas MenziusoAltimmune filed an initial beneficial ownership statement for Principal Accounting Officer Richard Thomas Menziuso on Oct. 2.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Altimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL1qJGyT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT","LU1878469433.USD","BK4139","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672574696","title":"Former Eli Lilly Exec Sells Wyoming Estate for Close to $39.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2672574696","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672574696?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:30","pubTimestamp":1790969400,"startTime":"0","endTime":"0","summary":"A former executive at Eli Lilly-maker of popular weight-loss drug Zepbound-has sold a roughly 117-acre estate in the Jackson Hole, Wyo., area for close to its asking price of $39.5 million in one of t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","LU2168564495.EUR","LU2324357040.USD","LU0417517546.SGD","LU0466842654.USD","IE00BN29S564.USD","IYH","LU2089283258.USD","LU2361044865.SGD","LU0203201768.USD","LU2112291526.USD","LU1988902786.USD","IE0001KFT4U8.USD","LU1979441026.SGD","IXJ","LU2264538146.SGD","GDOC","PJP","PPH","LU0106261372.USD","IE00B4JS1V06.HKD","LU0640476718.USD","LU0471298694.HKD","LU1712237335.SGD","LU1064131342.USD","LU2237443978.SGD","FTXH","LU0889565916.HKD","VHT","MEDI","SG9999015986.USD","SGXZ99366536.SGD","LU0823434740.USD","LU1629891620.HKD","LU1023059063.AUD","LU0122379950.USD","LU1917777945.USD","LU2237438978.USD","LU1069344957.HKD","LU2108987350.USD","LU1366192091.USD","LU2360106947.USD","LU2756315664.SGD","LU0353189763.USD","LU1127390331.HKD","LLYX","LU0353189680.USD","LU0114720955.EUR","LU1280957306.USD","LU2023251221.USD","GB00BDT5M118.USD","LU0094547139.USD","IE00B7KXQ091.USD","IE00BWXC8680.SGD","LU1804176565.USD","LU0820561818.USD","BK4581","LU1720051017.SGD","IE00BJJMRY28.SGD","LU2063271972.USD","LU0109391861.USD","FHLC","LU0174119429.USD","LU0385154629.USD","IE00BK4W5M84.HKD","BK4599","LU2237443622.USD","SG9999018865.SGD","LU0198837287.USD","LU2168563687.JPY","SGXZ31699556.SGD","LU0109394709.USD","LU1868837300.USD","LU2028103732.USD","LU2089284900.SGD","SG9999015952.SGD","LU1868836757.USD","BK4585","LU1989771016.USD","IE00B1XK9C88.USD","LU0210536198.USD","LU2089984988.USD","LU2552382215.SGD","IE00BKDWB100.SGD","LU0354030438.USD","IE00BKPKM429.USD","LU2552382058.USD","RXL","LU2491050154.USD","CURE","LU0320765992.SGD","LU2237443895.HKD","SGXZ81514606.USD","LU2750360997.AUD","IE00BJLML261.HKD","LU2462591350.SGD","LU0354030511.USD","IE00BFSS8Q28.SGD","IE0002141913.USD","LU2211815571.USD","BK4007","LU2168564065.EUR","BK4534","HRTS","LU2023250504.SGD","LU0964807845.USD","SG9999014906.USD","LU2462157665.USD","LU0158827781.USD","ELIS","LU0097036916.USD","LU1035775433.USD","SG9999014880.SGD","LU2111349929.HKD","LU1551013342.USD","LU1814569148.SGD","LU2552382132.HKD","LU2357305700.SGD","LU2236285917.USD","LU2750360641.GBP","SG9999015978.USD","LU2491050071.SGD","LU2756315318.SGD","MHIP","LU2271345857.HKD","LU2471134952.CNY","LU1057294990.SGD","LU2168564149.EUR","MEDX","LU0158827948.USD","THNR","IE0005OL40V9.USD","LU2602419157.SGD","LU0787776722.HKD","IE00B4R5TH58.HKD","LU0820561909.HKD","LU0256863902.USD","LU0882574055.USD","LU0345770993.USD","LU1093756325.SGD","ILDR","CANC","IE00B775H168.HKD","LU1323610961.USD","LU2361045086.USD","LU1061106388.HKD","LU2361044949.HKD","LU1551013425.SGD","LU1720051108.HKD","LU2168564222.USD","LU0823434583.USD","IE00BJJMRX11.SGD","LU2471134796.USD","BK4533","IE0009355771.USD","LU0316494557.USD","LU0943347566.SGD","LU2237443465.HKD","SG9999014914.USD","LU0432979614.USD","LU1868836914.USD","LU2456880835.USD","SG9999018857.SGD","TMED","LU1983299246.USD","LU1232071149.USD","XLV","LU2237443382.USD","LU0320765059.SGD","BK4516","LU2746668974.SGD","LU2896262040.SGD","LU2491049909.HKD","IHE","LU2746668461.USD","SG9999013999.USD","LU0456855351.SGD","LU1093756168.USD","LU0256863811.USD","IE00B1BXHZ80.USD","LU2106854487.HKD","LU0238689110.USD","LU1868837136.USD","LU1868836591.USD","LU2265009873.SGD","OZEM","LU1548497426.USD","LU0266013472.USD","LLII","IE0004445239.USD","IE00BK4W5L77.USD","BK4588","LU0006306889.USD","LU0820562030.AUD","LU2023250330.USD","LU0345770308.USD","JDOC","LU0203202063.USD","LU2237443549.SGD","IE00BFSS7M15.SGD","IE00B2B36J28.USD","TRUH","WDNA","SG9999001176.SGD","LU0689472784.USD","SG9999017495.SGD","LU0683600562.USD","LU0823416689.USD","LU0133085943.USD","LU2471134523.USD","SG9999015945.SGD","LU0096364046.USD","LU0323591593.USD","LU0471298777.SGD","LU2461242641.AUD","IE00BJT1NW94.SGD","LU1291159041.SGD","SG9999014898.SGD","LU2417539215.USD","LU0708995401.HKD","LLYZ","LLY","LU0079474960.USD","LU2087625088.SGD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0672654240.SGD","LU1267930730.SGD","SG9999001176.USD","LU2213496289.HKD","LU0061475181.USD","LU0786609619.USD","LU0289739699.SGD","ELIL","LU0882574139.USD","LU2471134879.HKD","LU1691799644.USD","LU1623119135.USD","LU0058720904.USD","LU0225283273.USD","IE0004445015.USD","AGNG","SGXZ51526630.SGD","IE00BJJMRZ35.SGD","LU1145028129.USD","SGXZ57979304.SGD","LU0234572021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672746160","title":"Eli Lilly announces FDA approves additional indication for Jaypirca","url":"https://stock-news.laohu8.com/highlight/detail?id=2672746160","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672746160?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:10","pubTimestamp":1790968214,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) and Company announced that the U.S. Food and Drug Administration FDA has approved an additional indication for Jaypirca, a non-cova...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-announces-fda-approves-additional-indication-for-jaypirca-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-announces-fda-approves-additional-indication-for-jaypirca-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4JS1V06.HKD","SG9999001176.USD","LU2750360997.AUD","LU0345770993.USD","LU0640476718.USD","LU2106854487.HKD","LU2357305700.SGD","LU2361045086.USD","LU2461242641.AUD","IE0002141913.USD","IE0001KFT4U8.USD","RXL","LU0345770308.USD","LU0210536198.USD","LU2324357040.USD","LU0289739699.SGD","GDOC","LU2028103732.USD","LU1974910355.USD","LU0787776722.HKD","LU0471298777.SGD","LU1280957306.USD","LU1814569148.SGD","BK4581","LU2602419157.SGD","LU0006306889.USD","WDNA","LU1720051017.SGD","LU2023250330.USD","LU0471298694.HKD","LU2111349929.HKD","LU2213496289.HKD","IE00BJJMRZ35.SGD","LU0320765059.SGD","BK4534","LU0238689110.USD","IE00BK4W5M84.HKD","LU1291159041.SGD","LU0889565916.HKD","MEDX","LU0353189763.USD","IE00BFTCPJ56.SGD","IXJ","LU1989771016.USD","IE00B1XK9C88.USD","LU2471134523.USD","LU2756315664.SGD","SGXZ31699556.SGD","LU1804176565.USD","IE00B1BXHZ80.USD","LU1983299246.USD","IE00BKPKM429.USD","LU2168564222.USD","LU2237438978.USD","SG9999013999.USD","SG9999014906.USD","LU0203202063.USD","LU0234572021.USD","LU1720051108.HKD","IE00BJT1NW94.SGD","LU2491049909.HKD","TMED","IE00B775H168.HKD","SG9999015945.SGD","SG9999001176.SGD","BK4533","AGNG","LU1691799644.USD","GB00BDT5M118.USD","LU2552382132.HKD","SG9999015986.USD","LU2468319806.SGD","BK4599","LU0964807845.USD","LU1868836591.USD","LLYZ","LU0256863902.USD","XLV","LU1127390331.HKD","SG9999018865.SGD","LU0158827948.USD","THNR","IE00BK4W5L77.USD","LU1712237335.SGD","LU0882574055.USD","SG9999015952.SGD","LU2063271972.USD","LU0097036916.USD","IE00BJJMRX11.SGD","LU2552382058.USD","LU0225283273.USD","LU0109394709.USD","IE00BFSS8Q28.SGD","LU0158827781.USD","LU1093756168.USD","LU1988902786.USD","BK4007","LU2750360641.GBP","CURE","LU2552382215.SGD","IE00BKDWB100.SGD","IE00BN29S564.USD","LU2089284900.SGD","LU0203201768.USD","LU2471134796.USD","LU1917777945.USD","LU0096364046.USD","LU0079474960.USD","LU0354030438.USD","LU0882574139.USD","LU1551013425.SGD","LU2237443622.USD","IE00B4R5TH58.HKD","LU2417539215.USD","LU1057294990.SGD","LU1979441026.SGD","LLYX","LU0820561818.USD","IE00B7KXQ091.USD","LU0943347566.SGD","FTXH","LU2087625088.SGD","LU1868837136.USD","LU0114720955.EUR","IE00BJLML261.HKD","LU0466842654.USD","LU0823416689.USD","LU0323591593.USD","LU1093756325.SGD","LU1145028129.USD","LU0417517546.SGD","LU0198837287.USD","LU2746668461.USD","IYH","LU1267930730.SGD","LU0820561909.HKD","LU2264538146.SGD","LU2756315318.SGD","LU2491050154.USD","FHLC","IE00BWXC8680.SGD","LU0786609619.USD","PPH","LU0320765992.SGD","LU0708995401.HKD","LU2236285917.USD","LU0820562030.AUD","BK4585","LU1623119135.USD","SGXZ99366536.SGD","LU1323610961.USD","LU2271345857.HKD","LU0133085943.USD","LU2112291526.USD","LU2237443978.SGD","SG9999017495.SGD","IE00B2B36J28.USD","LU0106261372.USD","LU1069344957.HKD","LLII","LU2746668974.SGD","MHIP","LU0354030511.USD","ILDR","LU1868837300.USD","LU0094547139.USD","LU2108987350.USD","LLY","LU0109391861.USD","SGXZ81514606.USD","LU0256863811.USD","LU2360106947.USD","LU0266013472.USD","LU1551013342.USD","LU1629891620.HKD","LU2491050071.SGD","LU2168564065.EUR","VHT","LU1061106388.HKD","SG9999014898.SGD","IE00BJJMRY28.SGD","LU1232071149.USD","LU2168564149.EUR","LU2361044949.HKD","BK4516","ELIS","OZEM","LU1868836757.USD","IE0004445015.USD","LU0672654240.SGD","JDOC","LU2462157665.USD","TRUH","LU0058720904.USD","IHE","IE0005OL40V9.USD","LU2168563687.JPY","BK4588","LU2237443895.HKD","LU0456855351.SGD","LU2456880835.USD","SG9999018857.SGD","IE0009355771.USD","LU1035775433.USD","LU1868836914.USD","LU2471134952.CNY","SGXZ57979304.SGD","LU0174119429.USD","LU0061475181.USD","LU2896262040.SGD","SG9999015978.USD","LU2211815571.USD","SG9999014880.SGD","LU2237443549.SGD","LU1023059063.AUD","LU2089984988.USD","LU0316494557.USD","LU0823434583.USD","LU1064131342.USD","ELIL","LU0689472784.USD","IE00BFSS7M15.SGD","LU0432979614.USD","PJP","LU0122379950.USD","LU2168564495.EUR","IE0004445239.USD","LU0683600562.USD","LU2089283258.USD","LU2237443382.USD","LU2471134879.HKD","CANC","LU2237443465.HKD","LU2361044865.SGD","LU0823434740.USD","LU2265009873.SGD","LU2023250504.SGD","LU2462591350.SGD","MEDI","HRTS","LU2023251221.USD","SG9999014914.USD","LU0353189680.USD","LU0385154629.USD","LU1366192091.USD","LU1548497426.USD","SGXZ51526630.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672465897","title":"Lilly Says FDA Approves Expanded First-Line Cll/sll Use for Jaypirca","url":"https://stock-news.laohu8.com/highlight/detail?id=2672465897","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672465897?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:06","pubTimestamp":1790967978,"startTime":"0","endTime":"0","summary":"Lilly says FDA approves expanded first-line CLL/SLL use for JaypircaFDA cleared Lilly’s Jaypirca (pirtobrutinib) for first-line treatment of adults with CLL/SLL with no known 17p deletion.Decision exp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL3s639g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFSS7M15.SGD","LU2361044949.HKD","LU2271345857.HKD","IE0004445239.USD","LU2896262040.SGD","LU1280957306.USD","SG9999013999.USD","LU0820561909.HKD","ELIL","IE00BN29S564.USD","IE00BFTCPJ56.SGD","LLYZ","IE0002141913.USD","TMED","MEDX","LU0096364046.USD","LU2087625088.SGD","CURE","LU0345770308.USD","SG9999001176.SGD","LU2552382215.SGD","LU0210536198.USD","LU2602419157.SGD","IE00BJJMRY28.SGD","IHE","LU0417517546.SGD","IE00B7KXQ091.USD","LU0354030511.USD","LU0097036916.USD","FTXH","LU1720051108.HKD","LU0158827948.USD","GDOC","MHIP","XLV","IYH","FHLC","LU0456855351.SGD","LU0882574139.USD","VHT","LU1720051017.SGD","BK4534","LU1917777945.USD","LU0943347566.SGD","LU2237443978.SGD","LU2237443465.HKD","LU2552382132.HKD","SG9999018857.SGD","IE00BJT1NW94.SGD","LU0174119429.USD","LU2112291526.USD","BK4599","LU1988902786.USD","LU0094547139.USD","LU2023250330.USD","HRTS","LU2468319806.SGD","LU2168564065.EUR","LU0787776722.HKD","LU0882574055.USD","LU1023059063.AUD","LU1061106388.HKD","LU2361045086.USD","SG9999015986.USD","LU0109391861.USD","LU2168563687.JPY","LU0006306889.USD","LU2211815571.USD","LU1232071149.USD","LU0353189680.USD","LU0471298777.SGD","LU2089284900.SGD","SG9999014914.USD","IE00BJLML261.HKD","LU0203201768.USD","LLII","LU0385154629.USD","IE0004445015.USD","LU1623119135.USD","LU2023251221.USD","LU2417539215.USD","GB00BDT5M118.USD","LU0345770993.USD","LU0708995401.HKD","LU0466842654.USD","BK4533","LU2023250504.SGD","LU0689472784.USD","IE00B2B36J28.USD","IE0005OL40V9.USD","SG9999015945.SGD","LU0079474960.USD","IE00B1BXHZ80.USD","LU1814569148.SGD","LU2491050071.SGD","BK4007","LU2237443895.HKD","IE00B1XK9C88.USD","SG9999014906.USD","LU2360106947.USD","AGNG","LU2361044865.SGD","SG9999015952.SGD","LU1323610961.USD","LU2491049909.HKD","LLYX","LU1064131342.USD","LU0316494557.USD","LU2108987350.USD","LU2471134879.HKD","LU0158827781.USD","LU0256863902.USD","IE00BK4W5M84.HKD","LU0109394709.USD","LU0061475181.USD","LU0820561818.USD","IE00B775H168.HKD","LU0114720955.EUR","LU2756315318.SGD","BK4588","IE00BK4W5L77.USD","LU0823434740.USD","IE0001KFT4U8.USD","LU0323591593.USD","LU1035775433.USD","LU1989771016.USD","LU2324357040.USD","LU2168564495.EUR","LU0823416689.USD","LU2471134952.CNY","LU2491050154.USD","LU0823434583.USD","LU1093756168.USD","LU1267930730.SGD","LU1551013425.SGD","LU2265009873.SGD","LU2264538146.SGD","IE00BJJMRZ35.SGD","LU0203202063.USD","LU2168564222.USD","LU2756315664.SGD","LU2552382058.USD","IE00BJJMRX11.SGD","LU2111349929.HKD","RXL","LU2089984988.USD","SGXZ99366536.SGD","SGXZ51526630.SGD","LU0889565916.HKD","LU1127390331.HKD","LU0320765992.SGD","SG9999017495.SGD","LU0471298694.HKD","SG9999014880.SGD","LU0432979614.USD","LU2237443549.SGD","LU1069344957.HKD","LU0353189763.USD","LLY","LU1974910355.USD","SGXZ81514606.USD","LU1629891620.HKD","SG9999015978.USD","LU1551013342.USD","LU2750360641.GBP","LU0234572021.USD","LU1868837136.USD","LU0266013472.USD","ELIS","BK4516","LU1979441026.SGD","IE00B4R5TH58.HKD","LU1804176565.USD","LU2746668461.USD","LU0225283273.USD","LU2461242641.AUD","THNR","LU1057294990.SGD","LU2746668974.SGD","SGXZ57979304.SGD","LU0964807845.USD","IE00B4JS1V06.HKD","LU0058720904.USD","LU2063271972.USD","LU2028103732.USD","LU2750360997.AUD","LU2462591350.SGD","BK4585","LU0122379950.USD","PPH","CANC","LU0786609619.USD","LU2237443622.USD","JDOC","LU2471134523.USD","LU1691799644.USD","LU2237443382.USD","LU0256863811.USD","LU2168564149.EUR","TRUH","LU0672654240.SGD","LU1548497426.USD","SGXZ31699556.SGD","LU1868836757.USD","LU1712237335.SGD","LU0683600562.USD","LU2213496289.HKD","IE00BKDWB100.SGD","LU1868837300.USD","BK4581","ILDR","LU0320765059.SGD","PJP","LU2471134796.USD","LU0133085943.USD","LU0289739699.SGD","LU2462157665.USD","MEDI","SG9999018865.SGD","LU0820562030.AUD","LU2106854487.HKD","LU1145028129.USD","SG9999014898.SGD","LU0238689110.USD","LU2357305700.SGD","IE00BKPKM429.USD","IE00BWXC8680.SGD","LU2089283258.USD","LU1093756325.SGD","LU2236285917.USD","SG9999001176.USD","LU1983299246.USD","IE00BFSS8Q28.SGD","LU1868836591.USD","WDNA","LU1291159041.SGD","LU1868836914.USD","LU2237438978.USD","OZEM","LU0198837287.USD","LU0640476718.USD","IE0009355771.USD","IXJ","LU2456880835.USD","LU0354030438.USD","LU0106261372.USD","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672874637","title":"Lilly's Jaypirca (Pirtobrutinib), the First-and-Only Approved Non-Covalent Btk Inhibitor, Receives Expanded Indication from U.S. FDA for Certain Patients with Previously Untreated Cll/Sll","url":"https://stock-news.laohu8.com/highlight/detail?id=2672874637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672874637?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:05","pubTimestamp":1790967939,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nTUA8VSLSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TMED","IE0004445239.USD","IE0005OL40V9.USD","SG9999014880.SGD","LU0786609619.USD","ELIL","LU1868836591.USD","ILDR","LU0058720904.USD","LU0353189680.USD","LU0787776722.HKD","LU1280957306.USD","LU1366192091.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU2746668974.SGD","LU0466842654.USD","SGXZ31699556.SGD","LU2168564149.EUR","BK4581","LU0889565916.HKD","GDOC","LU2028103732.USD","TRUH","LU1804176565.USD","LU2237438978.USD","LU0203202063.USD","LU0174119429.USD","LU0823416689.USD","LU0289739699.SGD","IE00B775H168.HKD","LU2236285917.USD","LU2361045086.USD","IE00BJJMRY28.SGD","LU2491050071.SGD","SG9999014906.USD","BK4533","SGXZ51526630.SGD","LU1057294990.SGD","LU0882574055.USD","LU2417539215.USD","LU0471298694.HKD","LU2108987350.USD","LU2756315318.SGD","LU2089283258.USD","LU2361044949.HKD","LU2471134952.CNY","LU0689472784.USD","IE00BWXC8680.SGD","BK4516","SG9999017495.SGD","BK4534","LU2168564065.EUR","SG9999015978.USD","SGXZ99366536.SGD","LU0943347566.SGD","LU2023250504.SGD","LU1623119135.USD","SG9999001176.SGD","LU1127390331.HKD","LU1232071149.USD","LU0708995401.HKD","LU2552382215.SGD","LU1988902786.USD","LU2265009873.SGD","LU2361044865.SGD","LU2112291526.USD","LU0109394709.USD","LU0354030511.USD","LU1267930730.SGD","LU0061475181.USD","MEDX","LU0096364046.USD","LU2756315664.SGD","IE00BJJMRX11.SGD","LU0203201768.USD","IE00BJLML261.HKD","LU2746668461.USD","LU1989771016.USD","LU1548497426.USD","LU0225283273.USD","IE00B7KXQ091.USD","LU2471134523.USD","LU0079474960.USD","LU1720051017.SGD","LU2461242641.AUD","IXJ","IE0009355771.USD","LU0158827948.USD","VHT","LU0256863902.USD","FHLC","FTXH","LU0672654240.SGD","LU0097036916.USD","IE00BJT1NW94.SGD","LU2471134879.HKD","LU2360106947.USD","BK4007","LU0114720955.EUR","GB00BDT5M118.USD","LU0133085943.USD","LU0345770308.USD","LU2168564222.USD","LU2462157665.USD","LU2750360997.AUD","LU0106261372.USD","LU0266013472.USD","LU2111349929.HKD","SG9999013999.USD","LU1023059063.AUD","SG9999018865.SGD","LU2552382132.HKD","LU0234572021.USD","LU2462591350.SGD","IE00BFTCPJ56.SGD","OZEM","LU2168563687.JPY","LU2237443382.USD","SG9999014898.SGD","IE00B1BXHZ80.USD","IE00BKPKM429.USD","LU0964807845.USD","LU1093756325.SGD","LU2264538146.SGD","LU0210536198.USD","PPH","LU2023250330.USD","IHE","LU2237443465.HKD","LU1061106388.HKD","LU0823434740.USD","LU1720051108.HKD","JDOC","AGNG","IE0001KFT4U8.USD","LU2468319806.SGD","LU0683600562.USD","LU1069344957.HKD","IE00B4JS1V06.HKD","LU2089984988.USD","LU0256863811.USD","LU1868837300.USD","LU2168564495.EUR","IE00BK4W5L77.USD","SG9999014914.USD","LU0820561909.HKD","LU2491049909.HKD","LU1868836914.USD","LU2211815571.USD","LU2213496289.HKD","LU1323610961.USD","SG9999018857.SGD","SGXZ57979304.SGD","LLYZ","LU0417517546.SGD","CANC","THNR","SG9999015945.SGD","LU2023251221.USD","LU1868836757.USD","LU2271345857.HKD","LU2471134796.USD","CURE","LU1629891620.HKD","LU2602419157.SGD","BK4599","LU0323591593.USD","MEDI","LLII","LU1974910355.USD","LU1064131342.USD","LU1035775433.USD","LU1712237335.SGD","LU0823434583.USD","IYH","LU0320765992.SGD","LU0432979614.USD","IE00BKDWB100.SGD","LU2357305700.SGD","ELIS","IE00BFSS8Q28.SGD","SG9999015952.SGD","LU2087625088.SGD","LU2896262040.SGD","LU1983299246.USD","LLY","LU1814569148.SGD","LU2750360641.GBP","LU1691799644.USD","LU2237443895.HKD","WDNA","PJP","LU0122379950.USD","LU0471298777.SGD","SGXZ81514606.USD","LU1291159041.SGD","LU0385154629.USD","LU0353189763.USD","LU0456855351.SGD","LU2456880835.USD","BK4585","LU1145028129.USD","LU1868837136.USD","LU1551013425.SGD","LU1093756168.USD","LU2324357040.USD","LU2552382058.USD","LU2237443549.SGD","HRTS","IE00BFSS7M15.SGD","IE00BJJMRZ35.SGD","RXL","SG9999001176.USD","IE00B2B36J28.USD","LU1551013342.USD","LU0238689110.USD","LU2491050154.USD","BK4588","LU0109391861.USD","LU1979441026.SGD","LU0198837287.USD","LU2106854487.HKD","IE0004445015.USD","LU0006306889.USD","LU0820561818.USD","LU0820562030.AUD","IE00BN29S564.USD","LU1917777945.USD","MHIP","LU0158827781.USD","LU0640476718.USD","LU2237443978.SGD","LU0354030438.USD","LU0882574139.USD","LU2089284900.SGD","IE00B1XK9C88.USD","IE00BK4W5M84.HKD","XLV","LU0316494557.USD","LLYX","LU2237443622.USD","SG9999015986.USD","LU2063271972.USD","LU0345770993.USD","LU0094547139.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672453137","title":"Pfizer Says Litfulo Safety Profile in NSV Consistent with Alopecia Areata","url":"https://stock-news.laohu8.com/highlight/detail?id=2672453137","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672453137?lang=en_us&edition=fundamental","pubTime":"2026-10-03 01:24","pubTimestamp":1790961886,"startTime":"0","endTime":"0","summary":"BRIEF-Pfizer Says Litfulo Safety Profile In NSV Consistent With Alopecia AreataOct 2 (Reuters)-Pfizer Inc.PFE.N:PFIZER’S LITFULO SIGNIFICANTLY IMPROVED FACIAL AND TOTAL BODY REPIGMENTATION IN PATIENTS","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0A4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","LU0234572021.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","SG9999002224.SGD","SG9999002232.USD","BK4550","SG9999013999.USD","LU1057294990.SGD","SG9999011175.SGD","SGXZ57979304.SGD","LU0321505439.SGD","LU1883839398.USD","LU1066053197.SGD","LU0985481810.HKD","BK4592","BK4599","BK4007","IE0002270589.USD","LU0868494617.USD","BK4568","BK4533","BK4585","LU0306806265.USD","LU1894683264.USD","LU0289739699.SGD","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU0321505868.SGD","LU0306807586.USD","LU0122379950.USD","SG9999001176.USD","IE00B3T34201.USD","LU1023059063.AUD","LU1894683348.USD","BK4534","LU0225771236.USD","LU0225284248.USD","LU0456855351.SGD","LU0058720904.USD","OZEM","BK4588","LU1066051498.USD","SG9999001176.SGD","LU2596442595.SGD","PFE","BK4581","LU0170899867.USD","SG9999003800.SGD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672235743","title":"Pfizer Tilrekimig Data Support TSLP Role in Atopic Dermatitis, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672235743","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672235743?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:54","pubTimestamp":1790960085,"startTime":"0","endTime":"0","summary":"Pfizer's  phase II data for its monthly IL-4, IL-13 and TSLP drug tilrekimig showed placebo-adjusted EASI-75 responses of about 40% to 50%, supporting the potential benefit of adding TSLP inhibition in atopic dermatitis, UBS Securities said.The investment firm said in a note Thursday that the results appear competitive with next-generation agents and above Dupixent on a placebo-adjusted EASI-75 basis.The firm also noted low rates of eye-related adverse events and consistent trends in itch reduction, while the study's placebo response was lower than in some comparable trials.Pfizer has started phase III studies of tilrekimig in asthma and atopic dermatitis, including a head-to-head study against Dupixent. The program could become a meaningful commercial player if successful, according to the note.UBS has a neutral rating on the company's stock, with a $27 price target.Shares of Pfizer were down 2% in Friday afternoon trading.Price: 27.55, Change: -0.57, Percent Change: -2.04","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0321505439.SGD","BK4581","BK4568","LU0456855351.SGD","LU0985481810.HKD","LU0225771236.USD","OZEM","LU1066051498.USD","PFE","SG9999011175.SGD","SG9999001176.SGD","LU1894683348.USD","SG9999002232.USD","IE00BLSP4452.SGD","IE00B19Z3581.USD","LU0306807586.USD","BK4585","BK4588","LU0225284248.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999003800.SGD","IE00BLSP4239.USD","BK4533","LU0170899867.USD","LU0289739699.SGD","SG9999001176.USD","SG9999002224.SGD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU2596442595.SGD","BK4534","IE0002270589.USD","BK4007","IE000M9KFDE8.USD","BK4599","LU1066053197.SGD","SGXZ57979304.SGD","LU0058720904.USD","LU1894683264.USD","BK4550","LU0234572021.USD","LU0122379950.USD","LU0306806265.USD","LU1883839398.USD","IE00BBT3K403.USD","IE00B3T34201.USD","LU0868494617.USD","SG9999013999.USD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672743136","title":"Novo Nordisk Tests Zenagamtide Dosing to Sharpen Its Obesity Drug Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2672743136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672743136?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:31","pubTimestamp":1790958671,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The study Investigating the Effect of Post-dose Meal Timings and Water Vol...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-tests-zenagamtide-dosing-to-sharpen-its-obesity-drug-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-tests-zenagamtide-dosing-to-sharpen-its-obesity-drug-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154236417.USD","NVOH","PPH","THNR","IE00BKVL7J92.USD","NVOX","BK4532","BK4585","BK4599","LU1093756168.USD","IE00BZ1G4Q59.USD","NVO","BK4588","OZEM","NVOC","BK4007","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672174313","title":"Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise","url":"https://stock-news.laohu8.com/highlight/detail?id=2672174313","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672174313?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:30","pubTimestamp":1790958636,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s AMGN Evolocumab Study Highlights Subtle Edge in Cholesterol Drug Del...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-evolocumab-study-signals-quiet-efficiency-gains-for-cholesterol-franchise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-evolocumab-study-signals-quiet-efficiency-gains-for-cholesterol-franchise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242646821.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","BBH","LU0109394709.USD","LU0868494617.USD","BK4566","LU1057294990.SGD","LU0122379950.USD","LU0889565916.HKD","BK4599","BK4534","LU2112291526.USD","BK4588","IE0002141913.USD","IE00BJJMRZ35.SGD","PJP","PBE","IBB","SG9999001440.SGD","BK4585","LU1983299246.USD","BK4139","BK4533","TBXU","IBBQ","LU0289739699.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","AMGN","LU1571399168.USD","BK4581","LU2468319806.SGD","LU0320765992.SGD","LU1023059063.AUD","BIB","LU2089984988.USD","LU2242652126.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672156743","title":"Pfizer’s TACTIVE-U Breast Cancer Combo Trial Reaches Key Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2672156743","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672156743?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:30","pubTimestamp":1790958630,"startTime":"0","endTime":"0","summary":"Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has updated results from its TACTIVE-U Sub-Study C, a Phas...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-tactive-u-breast-cancer-combo-trial-reaches-key-milestone?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-tactive-u-breast-cancer-combo-trial-reaches-key-milestone?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1066053197.SGD","BK4534","LU0868494617.USD","IE00BLSP4239.USD","LU0058720904.USD","BK4585","LU1057294990.SGD","SG9999011175.SGD","SG9999001176.SGD","BK4599","BK4581","IE00B3T34201.USD","BK4568","SG9999002224.SGD","BK4588","IE00B19Z3B42.SGD","LU0306807586.USD","BK4533","LU1023059063.AUD","IE0002270589.USD","LU1066051498.USD","IE000M9KFDE8.USD","LU0456855351.SGD","SGXZ57979304.SGD","LU0225771236.USD","SG9999003800.SGD","LU1894683348.USD","PFE","LU1883839398.USD","LU0170899867.USD","SG9999001176.USD","LU0122379950.USD","SG9999013999.USD","BK4550","IE00BLSP4452.SGD","LU1894683264.USD","LU0289739699.SGD","LU0306806265.USD","LU0321505439.SGD","BK4007","LU0321505868.SGD","IE00BBT3K403.USD","LU0985481810.HKD","LU2596442595.SGD","OZEM","LU0234572021.USD","SG9999002232.USD","IE00B19Z3581.USD","LU0225284248.USD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672574802","title":"Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2672574802","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672574802?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:03","pubTimestamp":1790956980,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B shed 0.5% to DKK248.75 Friday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 1.1% to 2,596.93.This was the stock's second consecutive day of losses.The company closed DKK161.20 short of its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 4,305,929, compared to the 50-day average trading volume of 4,898,141.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","NVO","NVOC","NVOH","LU1093756325.SGD","NVOX","BK4599","OZEM","LU1093756168.USD","PPH","IE00BKVL7J92.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","THNR","BK4532","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672377748","title":"Pfizer Says Phase 3 Trials Show Litfulo Improves Repigmentation in Nonsegmental Vitiligo Patients at Week 52","url":"https://stock-news.laohu8.com/highlight/detail?id=2672377748","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672377748?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:15","pubTimestamp":1790954142,"startTime":"0","endTime":"0","summary":"Pfizer says Phase 3 trials show LITFULO improves repigmentation in nonsegmental vitiligo patients at Week 52Pfizer presented Phase 3 results showing LITFULO improved facial repigmentation and overall ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL6gVNgg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","BK4581","BK4568","LU0456855351.SGD","LU0985481810.HKD","LU0225771236.USD","OZEM","LU1066051498.USD","PFE","SG9999011175.SGD","SG9999001176.SGD","LU1894683348.USD","SG9999002232.USD","IE00BLSP4452.SGD","IE00B19Z3581.USD","LU0306807586.USD","BK4585","BK4588","LU0225284248.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999003800.SGD","IE00BLSP4239.USD","BK4533","LU0170899867.USD","LU0289739699.SGD","SG9999001176.USD","SG9999002224.SGD","LU0321505868.SGD","IE00B19Z3B42.SGD","LU2596442595.SGD","BK4534","IE0002270589.USD","BK4007","IE000M9KFDE8.USD","BK4599","LU1066053197.SGD","SGXZ57979304.SGD","LU0058720904.USD","LU1894683264.USD","BK4550","LU0234572021.USD","LU0122379950.USD","LU0306806265.USD","LU1883839398.USD","IE00BBT3K403.USD","IE00B3T34201.USD","LU0868494617.USD","SG9999013999.USD","BK4592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672748319","title":"Pfizer - to Submit Litfulo Phase 3 Data to FDA and Ema","url":"https://stock-news.laohu8.com/highlight/detail?id=2672748319","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672748319?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:15","pubTimestamp":1790954105,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0A4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0225771236.USD","LU0985481810.HKD","BK4581","BK4534","LU0225284248.USD","SG9999003800.SGD","IE00B3T34201.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0306807586.USD","IE00BBT3K403.USD","BK4592","SG9999011175.SGD","BK4550","PFE","IE0002270589.USD","LU0456855351.SGD","LU0321505868.SGD","BK4588","IE00B19Z3B42.SGD","SG9999002224.SGD","LU1883839398.USD","LU2596442595.SGD","BK4599","OZEM","LU0170899867.USD","LU0122379950.USD","LU0868494617.USD","LU1066053197.SGD","BK4007","LU0289739699.SGD","LU0306806265.USD","LU1057294990.SGD","LU1066051498.USD","BK4568","IE00BLSP4452.SGD","LU1894683348.USD","BK4533","BK4585","LU0234572021.USD","SG9999001176.SGD","SG9999001176.USD","SG9999002232.USD","SGXZ57979304.SGD","LU1023059063.AUD","LU0321505439.SGD","LU1894683264.USD","SG9999013999.USD","IE00BLSP4239.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":4,"totalSize":233,"code":"91000000","status":"200"}]}}